Adagene Inc. (ADAG) stock
ADAGNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.48−0.12 (-7.50%)
Close on Nov 17, 2026Market cap $87.66MP/E –Yield –
Earnings
Adagene's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
–
Not yet scheduled
Revenue, Q2 FY2023
$17.30M
Non-GAAP net loss per ordinary share, Q2 FY2023
$0.00
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of Adagene's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | Aug 12, 2026before the open | – | – | – | – | Release |
| Q4 FY2025ended Dec 31, 2025 | Apr 1, 2026after the close | – | – | – | – | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 12, 2025after the close | – | – | – | – | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 24, 2025before the open | – | – | – | – | Release |
| Q2 FY2024ended Jun 30, 2024 | Jul 25, 2024after the close | – | – | – | – | Release |
| Q4 FY2023ended Dec 31, 2023 | Jan 16, 2024after the close | – | – | – | – | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 31, 2023before the open | $17.30M | – | -$0.08 | $0.00 | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 28, 2023after the close | – | – | – | – | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 31, 2022before the open | – | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Adagene has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Adagene puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Adagene filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
See a number that looks wrong?